These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 21898382)

  • 81. Hepatocytes express abundant surface class I MHC and efficiently use transporter associated with antigen processing, tapasin, and low molecular weight polypeptide proteasome subunit components of antigen processing and presentation pathway.
    Chen M; Tabaczewski P; Truscott SM; Van Kaer L; Stroynowski I
    J Immunol; 2005 Jul; 175(2):1047-55. PubMed ID: 16002705
    [TBL] [Abstract][Full Text] [Related]  

  • 82. TAP-independent delivery of antigenic peptides to the endoplasmic reticulum: therapeutic potential and insights into TAP-dependent antigen processing.
    Yewdell JW; Snyder HL; Bacik I; Antón LC; Deng Y; Behrens TW; Bachi T; Bennink JR
    J Immunother; 1998 Mar; 21(2):127-31. PubMed ID: 9551364
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Functional regulation of immunoproteasomes and transporter associated with antigen processing.
    Hwang LY; Lieu PT; Peterson PA; Yang Y
    Immunol Res; 2001; 24(3):245-72. PubMed ID: 11817324
    [TBL] [Abstract][Full Text] [Related]  

  • 84. HIV type 1 abrogates TAP-mediated transport of antigenic peptides presented by MHC class I. Transporter associated with antigen presentation.
    Kutsch O; Vey T; Kerkau T; Hünig T; Schimpl A
    AIDS Res Hum Retroviruses; 2002 Nov; 18(17):1319-25. PubMed ID: 12487820
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Influences of transporter associated with antigen processing (TAP) on the repertoire of peptides associated with the endoplasmic reticulum-resident stress protein gp96.
    Arnold D; Wahl C; Faath S; Rammensee HG; Schild H
    J Exp Med; 1997 Aug; 186(3):461-6. PubMed ID: 9236199
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Presentation of endogenous viral proteins in association with major histocompatibility complex class II: on the role of intracellular compartmentalization, invariant chain and the TAP transporter system.
    Oxenius A; Bachmann MF; Ashton-Rickardt PG; Tonegawa S; Zinkernagel RM; Hengartner H
    Eur J Immunol; 1995 Dec; 25(12):3402-11. PubMed ID: 8566030
    [TBL] [Abstract][Full Text] [Related]  

  • 87. MHC class I-deficient metastatic tumor variants immunoselected by T lymphocytes originate from the coordinated downregulation of APM components.
    Garcia-Lora A; Martinez M; Algarra I; Gaforio JJ; Garrido F
    Int J Cancer; 2003 Sep; 106(4):521-527. PubMed ID: 12845647
    [TBL] [Abstract][Full Text] [Related]  

  • 88. MHC class I pathway is not required for the development of crescentic glomerulonephritis in mice.
    Li S; Holdsworth SR; Tipping PG
    Clin Exp Immunol; 2000 Dec; 122(3):453-8. PubMed ID: 11122254
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Bacterial proteins can be processed by macrophages in a transporter associated with antigen processing-independent, cysteine protease-dependent manner for presentation by MHC class I molecules.
    Campbell DJ; Serwold T; Shastri N
    J Immunol; 2000 Jan; 164(1):168-75. PubMed ID: 10605008
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Relationship between peptide selectivities of human transporters associated with antigen processing and HLA class I molecules.
    Daniel S; Brusic V; Caillat-Zucman S; Petrovsky N; Harrison L; Riganelli D; Sinigaglia F; Gallazzi F; Hammer J; van Endert PM
    J Immunol; 1998 Jul; 161(2):617-24. PubMed ID: 9670935
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Functional roles of TAP and tapasin in the assembly of M3-N-formylated peptide complexes.
    Chun T; Grandea AG; Lybarger L; Forman J; Van Kaer L; Wang CR
    J Immunol; 2001 Aug; 167(3):1507-14. PubMed ID: 11466371
    [TBL] [Abstract][Full Text] [Related]  

  • 92. TLR9 activation increases TAP-independent vesicular MHC class I processing in vivo.
    Chen L; Jondal M
    Scand J Immunol; 2009 Nov; 70(5):431-8. PubMed ID: 19874547
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Differential influence on cytotoxic T lymphocyte epitope presentation by controlled expression of either proteasome immunosubunits or PA28.
    van Hall T ; Sijts A; Camps M; Offringa R; Melief C; Kloetzel PM; Ossendorp F
    J Exp Med; 2000 Aug; 192(4):483-94. PubMed ID: 10952718
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Thermal stability of MHC class I-beta 2-microglobulin peptide complexes in the endoplasmic reticulum is determined by the peptide occupancy of the transporter associated with antigen processing complex.
    Owen BA; Pease LR
    J Immunol; 2001 Feb; 166(3):1740-7. PubMed ID: 11160219
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Major histocompatibility complex class I presentation of ovalbumin peptide 257-264 from exogenous sources: protein context influences the degree of TAP-independent presentation.
    Wick MJ; Pfeifer JD
    Eur J Immunol; 1996 Nov; 26(11):2790-9. PubMed ID: 8921970
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Recombinant expression of vaccinia virus-encoded TAP1 and TAP2 promotes MHC class I-restricted antigen presentation in a Syrian hamster cell line.
    Lobigs M; Müllbacher A
    Immunol Cell Biol; 1995 Apr; 73(2):181-4. PubMed ID: 7797238
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Murine transporter associated with antigen presentation (TAP) preferences influence class I-restricted T cell responses.
    Yellen-Shaw AJ; Laughlin CE; Metrione RM; Eisenlohr LC
    J Exp Med; 1997 Nov; 186(10):1655-62. PubMed ID: 9362526
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Long-term T cell memory requires the surface expression of self-peptide/major histocompatibility complex molecules.
    Markiewicz MA; Girao C; Opferman JT; Sun J; Hu Q; Agulnik AA; Bishop CE; Thompson CB; Ashton-Rickardt PG
    Proc Natl Acad Sci U S A; 1998 Mar; 95(6):3065-70. PubMed ID: 9501216
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Alternative peptide repertoire of HLA-E reveals a binding motif that is strikingly similar to HLA-A2.
    Lampen MH; Hassan C; Sluijter M; Geluk A; Dijkman K; Tjon JM; de Ru AH; van der Burg SH; van Veelen PA; van Hall T
    Mol Immunol; 2013 Jan; 53(1-2):126-31. PubMed ID: 22898188
    [TBL] [Abstract][Full Text] [Related]  

  • 100. To TAP or not to TAP: alternative peptides for immunotherapy of cancer.
    Marijt KA; van Hall T
    Curr Opin Immunol; 2020 Jun; 64():15-19. PubMed ID: 31952027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.